539148 — Shivalik Rasayan Share News
0.000.00%
Last trade - 00:00- IN₹3.35bn
- IN₹4.15bn
- IN₹3.68bn
Brief: Shivalik Rasayan Says US FDA Approved API Facility At Dahej
India's Shivalik Rasayan climbs on US FDA approval for facility
India's Shivalik Rasayan up as U.S. FDA completes inspection at Gujarat factory
Brief: Shivalik Rasayan Says US FDA Completes Inspection At API Facility At Dahej Unit
Brief: Shivalik Rasayan Says Approvals To Construct Rg-4 At Dahej Unit-I Received From GIDC
India's Shivalik Rasayan up on approval to start manufacturing at plant
Brief: Shivalik Rasayan Says All Required Licenses To Start Manufacturing At Newly Build Agro-Chemical Plant Received
Brief: Shivalik Rasayan Received Certificate Of Suitability For Pirfenidone From European Directorate For Quality Of Medicine & Healthcare
Brief: Shivalik Rasayan Re-Appoints Dr. Vimal Kumar Shrawat As Managing Director
India's Shivalik Rasayan rises after China regulator permits drug evaluation
Brief: Shivalik Rasayan Says Centre For Drug Evaluation, China Has Acknowledged Drug Master File Of Bendamustine API
Brief: Shivalik Rasayan Issued LOA To Medicamen Biotech
Brief: Shivalik Rasayan To Consider Proposal For Raising Funds
Brief: Shivalik Rasayan Ltd Dec Quarter Consol Net Profit Rises
Brief: India's Shivalik Rasayan June Quarter Consol Net Profit Falls
Brief: Shivalik Rasayan Gets Consent To Operate For New Pharma API Manufacturing Plant At Dahej, Gujarat
Brief: India's Shivalik Rasayan Dec Quarter Consol Net Profit Rises
Brief: India's Shivalik Rasayan Sept-Qtr Consol Net Profit Rises
Brief: India's Shivalik Rasayan June-Qtr Consol Net Profit Rises